Nigerian doctor leading major study on antiviral drug, Remdesivir, slated for trial treatment of COVID-19

A Nigerian doctor named Babafemi Taiwo is leading a major study on an antiviral drug named Remdesivir that appears to be effective in treating Coronavirus (COVID-19).

CNN interviewed Dr Babafemi Taiwo to discuss the result of Remdesivir in treating Coronavirus.

Preliminary results of Remdesivir show it can help hospitalized COVID-19 patients recover faster. 

Though Remdesivir, an antiviral drug made by Gilead Sciences, appears to help patients with Coronavirus recover faster, it does not significantly reduce death, according to preliminary data from the National Institutes of Health.

“The data shows that Remdesivir has a clear cut, significant, positive effect in diminishing,  the time of recovery,” the director of the National Institute of Allergy and Infectious Diseases, Dr Anthony Fauci said during a meeting between president Trump and Louisiana Governor John Bel Edwards. 

Related posts

Intersociety Says Tinubu’s Invitation For Pope Leo’s Inaugural Mass “Undeserved…Misguided,” Cites Worsening Violence In Nigeria

The Pope Versus The Populists: Can There Be Reconciliation?

ISWAP Kills 23 Farmers, Fishermen in Malam Karanti After False Assurance Of Safety